Moody Aldrich Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
Moody Aldrich Partners's CDNA Position: Q4 2021 in Review
Moody Aldrich Partners sold out of CareDx (CDNA) in Q4 2021, closing a stake of 125,497 shares — an estimated $7.95M sold.
Moody Aldrich Partners first reported a position in CDNA in Q3 2018 and held it in 5 quarters. The position peaked at $7.95M in Q3 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.
- Moody Aldrich Partners reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
- Moody Aldrich Partners sold 125,497 CareDx shares in Q4 2021, an estimated $7.95M.
- Moody Aldrich Partners first reported a position in CareDx in Q3 2018 and held it in 5 quarters.
- Moody Aldrich Partners's CareDx position peaked at $7.95M in Q3 2021.
- 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.
Based on Moody Aldrich Partners's 13F filing for Q4 2021, filed 2 Feb 2022.